Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study-Reference-Cited by-同舟云学术

Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study

Published:2018-08-29 Issue:4 Volume:2 Page:684-688
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Piran Siavash¹,Traquair Hugh¹,Chan Noel¹,Bhagirath Vinai¹,Schulman Sam¹

Affiliation:

1. Division of Hematology and Thromboembolism; Department of Medicine; Thrombosis and Atherosclerosis Research Institute; McMaster University; Hamilton ON Canada

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/rth2.12146/fullpdf

Reference27 articles.

1. Health effects of overweight and obesity in 195 countries over 25 years;Afshin;N Engl J Med,2017

2. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study;Holst;Circulation,2010

3. Dabigatran versus warfarin in the treatment of acute venous thromboembolism;Schulman;N Engl J Med,2009

4. Oral rivaroxaban for symptomatic venous thromboembolism;Bauersachs;N Engl J Med,2010

5. Oral apixaban for the treatment of acute venous thromboembolism;Agnelli;N Engl J Med,2013

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-27

2. Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK);Clinical and Translational Science;2024-06

3. Apixaban plasma concentrations in patients with obesity;European Journal of Clinical Pharmacology;2024-06-01

4. Traduction et republication de : « Prise en charge de la maladie thromboembolique veineuse associée au cancer chez les populations vulnérables »;La Revue de Médecine Interne;2024-06

5. Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study;Thrombosis Journal;2024-05-22